RT Journal Article
SR Electronic
T1 Changes in the prevalence of the common risk factors for non-communicable diseases in Uganda between 2014 and 2023: Informed by nationally representative cross-sectional surveys
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.09.04.24313080
DO 10.1101/2024.09.04.24313080
A1 Kusolo, Ronald
A1 Mutungi, Gerald
A1 Mbuliro, Mary
A1 Kajjura, Richard
A1 Wesonga, Ronald
A1 Bahendeka, Silver K.
A1 Guwatudde, David
YR 2024
UL http://medrxiv.org/content/early/2024/09/05/2024.09.04.24313080.abstract
AB Background Non-communicable diseases (NCDs) remain the biggest contributor to global mortality. Although communicable diseases still contribute highest to mortality in the African region, the proportion contributed by NCDs continues to rise. An important way to control NCDs is to focus on reducing the prevalence of the common NCD risk factors. As such, monitoring changes in the prevalence of these risk factors is essential for better NCD prevention planning. Uganda conducted its first nationally representative NCD risk factor survey in 2014, and a second in 2023. We analyzed the prevalence of the common NCD risk factors using data from the two surveys to identify which risk factors changed between 2014 and 2023.Methods Both surveys drew countrywide samples stratified by the four regions of the country, and by rural-urban locations. The World Health Organization’s STEPs tool was used to collect data on demographic and behavioral characteristics, and physical and biochemical measurements. We defined and calculated weighted prevalence of the following common NCD risk factors: high blood pressure, high blood glucose, overweight and obesity, current use of alcohol, current tobacco use, inadequate consumption of fruits and vegetables, inadequate physical activity, and sedentariness.Results The 2014 survey enrolled a total of 3906 participants, whereas that of 2023 enrolled 3694 participants. The NCD risk factor prevalences that increased significantly were: high blood glucose from 1.3% in 2014, to 2.9% in 2023 (p< 0.001); overweight and obesity from 19.4% in 2014 to 24.1% in 2023 (p< 0.001); current alcohol consumption from 28.5% in 2014, to 31.1% in 2023 (p=0.013); and sedentariness from 26.6% in 2014, to 31.9% in 2023 (p< 0.001). It is only the prevalence of current smoke tobacco use that decreased significantly from 9.6% in 2014, to 8.3% in 2023 (p= 0.046). Nationally, no significant changes were observed in the prevalence of high blood pressure, inadequate consumption of fruits and vegetables, and inadequate physical activity.Conclusions Most of the common NCD risk factors increased between 2014 and 2023. There is an agent need for the various stakeholders in Uganda to implement interventions targeting reduction in the prevalence of NCD risk factors to prevent the currently increasing burden of NCDs and associated mortality.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe conduct of the two surveys on which the findings reported in this article is based was supported with funding from: the Uganda government, the World Health Organization, the World Diabetes Foundation, and, the United Nations Development Program.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Conduct of the survey was approved by the Institutional Review Committee of Nsambya Hospital, Kampala, Uganda (Approval #: SFHN-2022-43), and registered by the Uganda.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe data on which analysis presented in this article can be accessed on request to Uganda's Ministry of Heath, through the corresponding author.